146 related articles for article (PubMed ID: 8993604)
1. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
Glauert HP; Hong JT; Leung LK; Wilson MW
Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604
[No Abstract] [Full Text] [Related]
2. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
Wilson MW; Leung LK; Hong JT; Glauert HP
Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588
[No Abstract] [Full Text] [Related]
3. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
4. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.
Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE
Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488
[TBL] [Abstract][Full Text] [Related]
5. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
6. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.
Hong JT; Wilson MW; Glauert HP
J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705
[TBL] [Abstract][Full Text] [Related]
7. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
[TBL] [Abstract][Full Text] [Related]
8. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
[TBL] [Abstract][Full Text] [Related]
9. Toxicological evaluation of peroxisome proliferators. Further cellular and molecular aspects.
Passilly P; Pacot C; Jannin B; Cherkaoui Malki M; Bardot O; Caira F; Clemencet MC; Latruffe N
Ann N Y Acad Sci; 1996 Dec; 804():716-8. PubMed ID: 8993603
[No Abstract] [Full Text] [Related]
10. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
[TBL] [Abstract][Full Text] [Related]
11. Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines.
Passilly P; Jannin B; Latruffe N
Eur J Biochem; 1995 May; 230(1):316-21. PubMed ID: 7601116
[TBL] [Abstract][Full Text] [Related]
12. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
13. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Huang CY; Wilson MW; Lay LT; Chow CK; Robertson LW; Glauert HP
Cancer Lett; 1994 Dec; 87(2):223-8. PubMed ID: 7812944
[TBL] [Abstract][Full Text] [Related]
14. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes.
Orellana A; Holuigue L; Hidalgo PC; Faúndez V; González A; Bronfman M
Eur J Biochem; 1993 Aug; 215(3):903-6. PubMed ID: 8354295
[TBL] [Abstract][Full Text] [Related]
15. Species differences in the hepatic response to a potent peroxisome proliferator.
Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
[No Abstract] [Full Text] [Related]
16. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
Hong JT; Yun YP
Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418
[TBL] [Abstract][Full Text] [Related]
17. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
18. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation.
Vanden Heuvel JP
Gen Pharmacol; 1996 Oct; 27(7):1123-9. PubMed ID: 8981056
[TBL] [Abstract][Full Text] [Related]
19. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes.
Foxworthy PS; White SL; Hoover DM; Eacho PI
Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728
[TBL] [Abstract][Full Text] [Related]
20. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats.
Leung LK; Glauert HP
Toxicology; 1998 Feb; 126(1):65-73. PubMed ID: 9585093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
